RightFit
RecruitingNot applicable

RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

Recovering From IPV Through Strengths and Empowerment (RISE) Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study compares two types of brief counseling for Veterans Health Administration (VHA) patients who have had abuse from an intimate partner in the past year. RISE offers up to 8 sessions, while Enhanced Care as Usual offers 1 session. The study tests which approach better improves confidence in handling challenges and other parts of health.

This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health. Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Get care at a study site or a community outpatient clinic linked to that site.
  • Report physical, emotional, or sexual abuse from an intimate partner in the past year on a VHA screening questionnaire.
  • Be able to understand and agree to join the study, including allowing counseling sessions to be recorded.

Who can't join

  • Have severe problems with thinking or memory.
  • Intend to kill yourself or someone else and have a specific plan.
  • Have untreated or unstable symptoms of mania (extremely high energy or mood) or psychosis (trouble knowing what is real).

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC) * report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA, and * be able to provide informed consent including permission to have intervention sessions recorded Exclusion Criteria: * severe cognitive impairment, * suicide or homicide intent with a specific plan * untreated or unstable symptoms of mania or psychosis

Study sites (3)

MA

  • VA Boston Healthcare System · Boston, MA 02130Katherine M Iverson, PhD · Study contactMore trials in Boston

MN

PA